Novo Nordisk Postdoctoral Research Fellow (2018)
- Project: Exploring a novel signalling in “dysfunctional” adipose tissue, mediating the cardiovascular complications of diabetes
Amy joined the Novo Nordisk Fellowship Programme to pursue her research interests in diabetic cardiovascular disease under the supervision of Professor Charalambos Antoniades and Professor Keith Channon. Amy's project aimed to investigate the role of an adipose tissue-derived ligand in the regulation of vascular redox state following diabetes.
Amy completed her PhD training studying diabetic cardiovascular complications, from the perspective of metabolism, in the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) in Canada.